Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
about
Cordyceps sinensis(a traditional Chinese medicine) for kidney transplant recipientsCordyceps sinensis(a traditional Chinese medicine) for kidney transplant recipientsMycophenolate mofetil for liver-transplanted patientsNuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerDe novo glomerular diseases after renal transplantationCyclosporine A induces apoptotic and autophagic cell death in rat pituitary GH3 cellsIdentification of Fyn as the binding partner for the WASP N-terminal domain in T cells.Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitisRecent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.Drug-associated renal dysfunction and injury.Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicityChronic kidney disease stage progression in liver transplant recipients.Cardiovascular complications of immunosuppressive agents in renal transplant recipients.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic miceNox2 is a mediator of chronic CsA nephrotoxicity.Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation.New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.Senescent Cells Contribute to the Physiological Remodeling of Aged LungsCalcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting DuctsIncidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantationCalcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.Nephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosisEstablished and newly proposed mechanisms of chronic cyclosporine nephropathyRole of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes.The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus.Hypertension in kidney transplant recipients.The management of hypertensive emergencies in children after stem cell transplantation.Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.Tacrolimus in transplant rejection.Population pharmacokinetics of cyclosporine in transplant recipients.Use of antioxidants to prevent cyclosporine a toxicity.Calcineurin inhibitor sparing strategies in renal transplantation, part one: Late sparing strategies.Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays.Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients.Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation.RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity.Incidence and risk factors for early renal dysfunction after liver transplantation.
P2860
Q24186537-236EA62A-7806-48A6-86B5-698A3FE43347Q24201391-563AF33D-DED8-4F17-BA4D-96235CEBA423Q24242476-3B6FCB4A-F9B6-446C-B5FC-22092274DD41Q26824937-0C83C8BC-A476-42B1-9E4C-95715DC14DA4Q27005877-E56807F1-1AEF-4F6F-89C8-696985BDE9D9Q28543660-6AE3D7A6-E3FB-4CE1-BEEE-D123F4A6B72BQ30010289-3331E57E-D071-478D-8095-13159EE9A593Q30405394-ADC8ACE7-D961-487A-880E-405B46E5D4E3Q34222209-1D6D2993-BD80-4CE0-ACD4-BE2891C82E88Q34289498-16B6F1F1-0D9F-436A-8230-711BF2D94ACAQ34560483-0FC70020-7454-4042-A867-FF100611FABAQ35385844-A0129D9C-9B1D-47FB-932B-841845BC9A9CQ35985673-D46BA173-F191-4D76-9A23-75645D3757D6Q36040739-8AC1424D-FB57-4C97-A85E-E11C060F22C8Q36061821-79CD70C2-8A9B-4A84-8F28-27D4CBE4910FQ36076393-DC6C7D02-40C2-47FF-BC23-8E0600A6DDE0Q36131113-3089E140-BDD0-4E72-BE74-52E1BB142713Q36761340-A3DD55E8-E16C-4D61-AF2C-546B029048F3Q36788871-F2822B5A-6D99-480E-B45A-A7985FCA8D00Q36885316-A2D7DFA0-ABE6-4B56-ABC7-501BBB4A6672Q36909084-04127765-FE9D-4BB9-84ED-A714CD304EA2Q36945333-A4B54A5D-2FC9-429B-B954-37C529911802Q37064446-4F0575CB-1A44-484B-99AE-AD0BDF882D75Q37175582-2DBF268A-7561-4C5F-80C8-57B8FCCE3AAAQ37232923-5B30FAFD-00EA-4609-A582-12C0334177D7Q37259666-E42C74D6-2A86-42EB-AC79-4141D46800D8Q37394389-050BF050-3C7F-4D81-9D41-0DC83DD7154BQ37410772-631D1DF1-773C-45EA-8937-09CBBF52E3BBQ37850471-53ED4804-0F10-416B-9FB5-6D1DE13B6B36Q37851883-A1E0D4C6-9808-4E32-A20F-0477E6025116Q37893563-F7D21018-E6AC-4578-92C4-26676C40E2EDQ38066267-34EC4684-A7A2-4531-B446-C2340562CDD2Q38115174-FCCA03BB-E076-4482-BE21-BC5DCF18D77EQ38166348-0F4D97F0-2184-4852-9AF9-BBBB840E9178Q38230449-861E707A-8585-49C2-8CF4-939621FE5C3CQ38359506-61ABBD9F-0C51-4C38-84C4-836B780CEAC4Q38435024-31A80D43-10EE-4868-B0D7-8D8D1D4B09A4Q38779438-E3812AA0-BCFC-41C6-A45A-4896FFF7FC0EQ39270508-09BBF102-577E-40C3-8F41-3BFB07CC902FQ39294134-0D710364-F35D-4533-A195-DAE566ABA882
P2860
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@ast
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@en
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@nl
type
label
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@ast
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@en
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@nl
prefLabel
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@ast
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@en
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@nl
P2093
P1476
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
@en
P2093
A J Olyaei
A M de Mattos
W M Bennett
P304
P356
10.1097/00075198-200112000-00003
P577
2001-12-01T00:00:00Z